|
OCRL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.15179999999426E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.350080E-04 |
| Normal-vs-Stage2 |
1.204750E-03 |
| Normal-vs-Stage3 |
1.641320E-04 |
| Normal-vs-Stage4 |
5.907800E-02 |
| Stage1-vs-Stage2 |
8.016000E-01 |
| Stage1-vs-Stage3 |
7.112000E-01 |
| Stage1-vs-Stage4 |
5.902200E-01 |
| Stage2-vs-Stage3 |
9.811800E-01 |
| Stage2-vs-Stage4 |
5.318200E-01 |
| Stage3-vs-Stage4 |
4.795400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.1103999999994E-05 |
| Normal-vs-AfricanAmerican |
3.082700E-03 |
| Normal-vs-Asian |
8.940800E-01 |
| Caucasian-vs-AfricanAmerican |
9.465200E-01 |
| Caucasian-vs-Asian |
2.510200E-01 |
| AfricanAmerican-vs-Asian |
2.290400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.08339999996365E-06 |
| Normal-vs-Female |
4.935000E-03 |
| Male-vs-Female |
4.321800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.916110E-02 |
| Normal-vs-Age(41-60Yrs) |
4.237800E-04 |
| Normal-vs-Age(61-80Yrs) |
7.66070000000063E-05 |
| Normal-vs-Age(81-100Yrs) |
4.09780000000248E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.179200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.789000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.174000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.339000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.856100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.021800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.249500E-02 |
| Normal-vs-Grade 2 |
1.798020E-04 |
| Normal-vs-Grade 3 |
1.87367999999744E-05 |
| Normal-vs-Grade 4 |
5.716000E-02 |
| Grade 1-vs-Grade 2 |
7.124000E-01 |
| Grade 1-vs-Grade 3 |
9.113400E-01 |
| Grade 1-vs-Grade 4 |
5.504400E-01 |
| Grade 2-vs-Grade 3 |
4.103600E-01 |
| Grade 2-vs-Grade 4 |
7.013000E-01 |
| Grade 3-vs-Grade 4 |
4.238000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.75330000032837E-07 |
| Normal-vs-ccB subtype |
1.587640E-02 |
| ccA subtype-vs-ccB subtype |
3.484100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.640800E-03 |
| Normal-vs-N1 |
5.038600E-01 |
| N0-vs-N1 |
7.139000E-01 |
|
|
